- Latest week
- 10 Jul 2026
- Close
- 2.480000
- Fair value
- 2.648566
- Next-week expectancy
- Negative 43.17%
ENZY Chart Pack
Enzymatica AB (publ)
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, ENZY fell 11.43%, moving from 2.80 to 2.48. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is -1.34 and has softened across the 12-week window. Market Dynamics is -0.61 on the latest week. Next-week expectancy is negative at 43.17% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 2.48
- 12-Week Change
- -11.43%
- Trend Signal
- Active
- Next-Week Expectancy
- Negative 43.17%
- Signal Weeks
- 12 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Below
- Relative Strength
- -1.34
- Market Dynamics
- -0.61
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 2.48
- 12-Week Change
- -11.43%
- Trend Signal
- Active
- Next-Week Expectancy
- Negative 43.17%
- Signal Weeks
- 12 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Below
- Relative Strength
- -1.34
- Market Dynamics
- -0.61
Over the latest 12 completed weeks ending 2026-07-10, ENZY fell 11.43%, moving from 2.80 to 2.48. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is -1.34 and has softened across the 12-week window. Market Dynamics is -0.61 on the latest week. Next-week expectancy is negative at 43.17% based on similar historical setup states.
Industry Peers
Sweden equities in Drug Manufacturers - Specialty & Generic
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| NEWBRY Newbury Pharmaceuticals AB (publ) | STO | 10 Jul 2026 | 2.06 | 2.50 | 1.22 | 2.42 | 17.48% |
| CINPHA Cinclus Pharma Holding AB (publ) | STO | 10 Jul 2026 | 11.28 | 12.20 | 11.18 | 11.98 | 6.21% |
| NANEXA Nanexa AB (publ) | STO | 10 Jul 2026 | 3.57 | 3.73 | 3.53 | 3.70 | 3.64% |
| ACUC AcuCort AB | STO | 10 Jul 2026 | 0.62 | 0.67 | 0.60 | 0.64 | 3.23% |
| MOB Moberg Pharma AB (publ) | STO | 10 Jul 2026 | 9.45 | 9.73 | 9.23 | 9.47 | 0.21% |
| PMED PEPTONIC Medical AB | STO | 10 Jul 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
| VIVE Vivesto AB | STO | 10 Jul 2026 | 8.50 | 9.18 | 8.10 | 8.45 | -0.59% |
| EQL EQL Pharma AB | STO | 10 Jul 2026 | 23.60 | 24.30 | 22.30 | 23.35 | -1.06% |
| SOBI Swedish Orphan Biovitrum AB (publ) | STO | 10 Jul 2026 | 480.00 | 487.00 | 470.60 | 471.20 | -1.83% |
| KLAR Klaria Pharma Holding AB (publ.) | STO | 10 Jul 2026 | 0.78 | 0.85 | 0.74 | 0.76 | -2.31% |
| BIOG-B BioGaia AB (publ) | STO | 10 Jul 2026 | 120.20 | 121.50 | 116.50 | 116.50 | -3.08% |
| ORX Orexo AB (publ) | STO | 10 Jul 2026 | 24.40 | 25.35 | 22.50 | 23.20 | -4.92% |
| CRNO-B Cereno Scientific AB (publ) | STO | 10 Jul 2026 | 5.13 | 5.21 | 4.70 | 4.83 | -5.93% |
| ALVO-SDB Alvotech SDB | STO | 10 Jul 2026 | 35.80 | 36.45 | 32.30 | 33.55 | -6.28% |
| DICOT Dicot Pharma AB | STO | 10 Jul 2026 | 0.21 | 0.21 | 0.18 | 0.19 | -7.16% |
| ODI ODI Pharma AB | STO | 10 Jul 2026 | 2.56 | 3.00 | 2.12 | 2.30 | -10.16% |